mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |